1. Sahu MK, Dubey RK, Chandker A, Kumar M, Kumar M, A systematic review and metaanalysis of serum and plasma cortisol levels in depressed patients versus controls. J Psychiatry.
2022; 64(15):440–448.
2. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for
195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140 -6736(18)32279-7. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44. doi: 10.1016/S0140-6736(19)31047-5.
3. Alves Vde M, Francisco LC, Belo FM, de-Melo Neto VL, Barros VG, Nardi AE. Evaluation of the quality of life and risk of suicide. Clinics (Sao Paulo). 2016 Mar;71(3) :135-9. doi:10.6061/clinics/2016(03)03.
4. Bertollo AG, Grolli RE, Plissari ME, Gasparin VA, Quevedo J, Réus GZ et al., Stress and serum cortisol levels in major depressive disorder: a cross-sectional study. AIMS Neurosci. 2020
Nov 13;7(4):459-469. doi: 10.3934/ Neuroscience.2020028.
5. Ignácio ZM, da Silva RS, Plissari ME, Quevedo J, Réus GZ. Physical Exercise and Neuro inflammation in Major Depressive Disorder. Mol Neurobiol. 2019 Dec;56(12):8323-8335. doi: 10.1007/s12035019-01670-1. Epub 2019 Jun 21.
6. Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr et al., HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017 Apr;22(4):527536. doi: 10.1038/mp.2016.120.
7. Monica T, Grecu L, Buicu GE, Ferencz M, Grecu M, Salcudean A et al. Increased cortisol levels in depression: A comparative study evaluating the correlation of hypercortisolemia
with prosocial coping mechanisms. Acta Medica Marisiensis 2016;62(1):68-72. doi: 10.1515/amma-2015-0116
8. Lovallo WR., Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol. 2006 Mar;59(3):195-202. doi: 10.1016/j.ijpsycho.2005.10.007.
9. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R et al., Major depressive disorder and hypothalamic pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009 Jun; 66(6): 617-26. doi: 10.1001/ archgen psychiatry .2009.50.
10. Yibrah M, Negesso AE, Gebregziabher A, Challa F, Mudi K, Tesfay F et al., Gonadal and Cortisol Hormone Profile among Male Chronic Khat, Marijuana, and Heroin Abuses. Int J
Endocrinol. 2019 Nov 3;2019:4178241. doi: 10.1155/2019/4178241. PMID: 31781207; PMCID: PMC6874973.
11. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006 May;49(5):837-45. doi: 10.1007/s00125-0060159-x. Epub 2006 Mar 7. PMID: 16520921.
12. Qi S, Xu Y, Zeng K, Li Y, Ma J. Incidence and Factors Associated with Hyperglycemia in Patients with First Hospitalization for Major Depression Disorder: A Large Cross-Sectional Sample. Neuropsychiatr Dis Treat. 2023 Aug 21;19:1809-1818. doi: 10.2147/NDT.S421984. PMID: 37637977; PMCID: PMC10455853.
13. Ojo O, Wang XH, Ojo OO, Ibe J., The Effects of Substance Abuse on Blood Glucose Parameters in Patients with Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2018 Nov 29;15(12):2691. doi: 10.3390/ijerph15122691.
14. Burgese DF, Bassitt DP., Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy. Trends Psychiatry Psychother. 2015 Jan-Mar;37(1):27-36. doi: 10.1590/2237-6089 2014-0031.
15. Nandam LS, Brazel M, Zhou M, Jhaveri DJ., Cortisol and Major Depressive Disorder Translating Findings From Humans to Animal Models and Back. Front Psychiatry. 2020 Jan 22;10:974. doi: 10.3389/fpsyt.2019.00974.
16. Alenko A, Markos Y, Fikru C, Tadesse E, Gedefaw L. Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive
disorder in Jimma medical center, Southwest Ethiopia. PLoS One. 2020 Oct 16; 15(10) :e0240668. doi: 10.1371/journal.pone. 0240668.
17. Ligabue KP, Schuch JB, Scherer JN, Ornell F, Roglio VS, Assunção V et al., Increased cortisol levels are associated with low treatment retention in crack cocaine users. Addict Behav. 2020
Apr;103:106260. doi: 10.1016/j.addbeh.2019.106260.
18. Joan C. Edwards School of Medicine - Marshall University [Internet]. New study identifies cortisol level as indicator of addiction recovery success; [cited 2026 Feb 6]. Available from:
https://jcesom.marshall. edu/news/ musomnews/new-study-identifies-cortisol-level-asindicator-of-addiction-recovery-success/.